H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.2% of adults in Omaha have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Census population 486,051. Nebraska Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Omaha clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Omaha storefront.
Regenerative Medicine for Athletic Performance in Omaha, NE for clinics & physicians. Regenerative medicin… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 10.2% of adults in Omaha have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Census city-proper population is 486,051. If you are adding regenerative medicine for athletes, start with that epidemiology and with WPS Government Health Administrators (J5) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Regenerative Medicine for Athletic Performance notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Omaha we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 10.2% of adults in Omaha have diagnosed diabetes — 1.8 points below the U.S. 12% figure.
We are not going to invent a Omaha warehouse or a five-star local review. What you get is regenerative medicine for athletes from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS J5, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 10.2% of adults — 1.8 points below the U.S. 12% figure. Obesity is 37.5%; arthritis is 21.4%. That is place-level BRFSS modeling, not a clinic census and not a Omaha trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Nebraska compliance risk.
City-proper counts are unambiguous and match the URL slug. MSA figures change with OMB delineations and would be easy to get wrong. We would rather under-claim than invent a metro number.
Nebraska is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
If you operate in Nebraska and another MAC state, say it on the first call. J5 will not port 1:1. We would rather split utilization than watch a sister clinic copy Omaha tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Omaha, NE.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Omaha is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Omaha — 1.8 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Nebraska Part B wound biologics follow this contractor (siblings: IA, KS, MO). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Omaha. Useful for joint-program math; still needs a diagnosis and privileging.
No Omaha storefront. Joe Bradley is an active practice owner. regenerative medicine for athletes stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.